CA9 and central nervous system cancer: To validate the findings obtained from the bioinformatic analysis, we conducted IHC assays for CA9 (a biomarker of hypoxia and glycolysis [21]), IL-2, and IL-6 proteins in glioma tissues obtained from our research cohort.